{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:33:10Z","timestamp":1778704390074,"version":"3.51.4"},"reference-count":103,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.gtc.2011.01.001","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T09:46:38Z","timestamp":1298022398000},"page":"121-139","source":"Crossref","is-referenced-by-count":22,"title":["Potential Biomarkers"],"prefix":"10.1016","volume":"40","author":[{"given":"Robin C.","family":"Spiller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2011.01.001_bib1","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1440-1746.2006.04543.x","article-title":"Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome","volume":"22","author":"Harish","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2011.01.001_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0016-5085(00)70251-4","article-title":"Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome","volume":"118","author":"Prather","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1053\/gast.2001.21166","article-title":"Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder","volume":"120","author":"Bouras","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2036.2002.01210.x","article-title":"Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation","volume":"16","author":"Sloots","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2982.2009.01378.x","article-title":"Effects of velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation","volume":"22","author":"Manini","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2011.01.001_bib6","doi-asserted-by":"crossref","first-page":"G942","DOI":"10.1152\/ajpgi.00264.2005","article-title":"Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers","volume":"290","author":"Camilleri","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.gtc.2011.01.001_bib7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.gastro.2007.06.067","article-title":"Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome","volume":"133","author":"Andresen","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2036.2000.00762.x","article-title":"Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers","volume":"14","author":"Houghton","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2036.1990.tb00458.x","article-title":"Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist","volume":"4","author":"Gore","year":"1990","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib10","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1023\/A:1014729125428","article-title":"Evolution of visceral sensitivity in patients with irritable bowel syndrome","volume":"47","author":"Poitras","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2011.01.001_bib11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2036.2008.03918.x","article-title":"Amitriptyline modifies the visceral hypersensitivity response to acute stress in the irritable bowel syndrome","volume":"29","author":"Thoua","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/gut.2004.047423","article-title":"Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome","volume":"54","author":"Morgan","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.01.001_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2036.2007.03566.x","article-title":"Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome","volume":"27","author":"Leventer","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib14","doi-asserted-by":"crossref","first-page":"A546","DOI":"10.1016\/S0016-5085(08)62548-2","article-title":"Mesalazine treatment for intestinal immune activation in patient with irritable bowel syndrome: a randomized controlled pilot","volume":"134","author":"Barbara","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib15","first-page":"A86","article-title":"Treatment with the mast cell stabilizer ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in IBS patients","volume":"57","author":"Klooker","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.01.001_bib16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1100\/tsw.2003.93","article-title":"Visceral Afferent Pathways and Functional Brain Imaging","volume":"3","author":"Derbyshire","year":"2003","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.gtc.2011.01.001_bib17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2036.2009.04144.x","article-title":"Measuring IBS patient reported outcomes with an abdominal pain numeric rating scale: results from the proof cohort","volume":"30","author":"Spiegel","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib18","first-page":"G650","article-title":"Altered sensitivity of the gallbladder to cholecystokinin octapeptide in the irritable bowel syndrome","volume":"253","author":"Kellow","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1016\/j.gtc.2011.01.001_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0016-5085(86)90445-2","article-title":"Decreased fluid tolerance, accelerated transit, and abnormal motility of the human colon induced by oleic acid","volume":"91","author":"Spiller","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2982.2010.01488.x","article-title":"Technical advances in monitoring human motility patterns","volume":"22","author":"Dinning","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2011.01.001_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2982.2001.00252.x","article-title":"Reproducibility of antroduodenal motility during prolonged ambulatory recording","volume":"13","author":"Penning","year":"2001","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2011.01.001_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1023\/A:1021734414976","article-title":"Abnormalities of left colonic motility in ambulant nonconstipated patients with irritable bowel syndrome","volume":"48","author":"Clemens","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2011.01.001_bib23","doi-asserted-by":"crossref","first-page":"G629","DOI":"10.1152\/ajpgi.2001.280.4.G629","article-title":"Ambulatory 24-h colonic manometry in healthy humans","volume":"280","author":"Rao","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.gtc.2011.01.001_bib24","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1572-0241.2004.40453.x","article-title":"Ambulatory 24-hour colonic manometry in slow-transit constipation","volume":"99","author":"Rao","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.01.001_bib25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10620-009-0772-x","article-title":"Reproducibility and performance characteristics of colonic compliance, tone, and sensory tests in healthy humans","volume":"55","author":"Odunsi","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2011.01.001_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2009.01.017","article-title":"Investigation of colonic and whole gut transit with wireless motility capsule and radio-opaque markers in constipation","author":"Rao","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2011.01.001_bib27","doi-asserted-by":"crossref","first-page":"G1107","DOI":"10.1152\/ajpgi.00136.2009","article-title":"Heightened colon motor activity measured by a wireless capsule in patients with constipation: relation to colon transit and IBS","volume":"297","author":"Hasler","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.gtc.2011.01.001_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0016-5085(87)90837-7","article-title":"Simplified assessment of segmental colonic transit","volume":"92","author":"Metcalf","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1542-3565(04)00726-8","article-title":"Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome","volume":"3","author":"Dunlop","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2011.01.001_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1532-5415.1998.tb01018.x","article-title":"Relation of colonic transit to functional bowel disease in older people: a population-based study","volume":"46","author":"Evans","year":"1998","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.gtc.2011.01.001_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2036.1994.tb00273.x","article-title":"Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome","volume":"8","author":"Gorard","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib32","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/gut.42.4.511","article-title":"Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers","volume":"42","author":"Emmanuel","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.01.001_bib33","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/j.1365-2036.2006.02940.x","article-title":"Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome","volume":"23","author":"Tack","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2982.2002.00304.x","article-title":"Effect of bowel cleansing on colonic transit in constipation due to slow transit or evacuation disorder","volume":"14","author":"Sloots","year":"2002","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2011.01.001_bib35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/gut.39.1.109","article-title":"How well does stool form reflect colonic transit?","volume":"39","author":"Degen","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.01.001_bib36","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archinte.161.14.1733","article-title":"A\u00a0randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome","volume":"161","author":"Camilleri","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.gtc.2011.01.001_bib37","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0016-5085(86)80004-X","article-title":"Colonic transit scintigraphy. A physiologic approach to the quantitative measurement of colonic transit in humans","volume":"91","author":"Krevsky","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib38","first-page":"882","article-title":"Cisapride accelerates colonic transit in constipated patients with colonic inertia [see comments]","volume":"84","author":"Krevsky","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.01.001_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0016-5085(91)90466-X","article-title":"Scintigraphic measurement of regional gut transit in idiopathic constipation","volume":"101","author":"Stivland","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4065\/70.2.113","article-title":"Scintigraphy of the whole gut: clinical evaluation of transit disorders","volume":"70","author":"Charles","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.gtc.2011.01.001_bib41","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/gut.42.5.628","article-title":"Medium-term effects of a new 5HT3\u00a0antagonist, alosetron, in patients with carcinoid diarrhoea","volume":"42","author":"Saslow","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.01.001_bib42","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1542-3565(04)00391-X","article-title":"Effect of renzapride on transit in constipation-predominant irritable bowel syndrome","volume":"2","author":"Camilleri","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2011.01.001_bib43","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0016-5085(92)91789-7","article-title":"Transit through the proximal colon influences stool weight in the irritable bowel syndrome","volume":"102","author":"Vassallo","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib44","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1046\/j.1365-2036.2002.01344.x","article-title":"Performance characteristics of scintigraphic transit measurements for studies of experimental therapies","volume":"16","author":"Cremonini","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib45","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2982.2008.01230.x","article-title":"American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice","volume":"20","author":"Camilleri","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2011.01.001_bib46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0016-5085(95)90267-8","article-title":"Altered rectal perception is a biological marker of patients with irritable bowel syndrome","volume":"109","author":"Mertz","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib47","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cgh.2008.02.060","article-title":"Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome","volume":"6","author":"Camilleri","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2011.01.001_bib48","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gut.2006.117390","article-title":"Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity","volume":"56","author":"Dorn","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.01.001_bib49","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-2982.2005.00709.x","article-title":"Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibility","volume":"17","author":"Cremonini","year":"2005","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2011.01.001_bib50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/j.gastro.2006.05.014","article-title":"Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients","volume":"131","author":"Naliboff","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib51","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/BF02064986","article-title":"Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism","volume":"40","author":"Zighelboim","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2011.01.001_bib52","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-2036.1998.00375.x","article-title":"Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome","volume":"12","author":"Delvaux","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2982.2003.00389.x","article-title":"Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials","volume":"15","author":"Cremonini","year":"2003","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2011.01.001_bib54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0016-5085(99)70226-X","article-title":"The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome","volume":"116","author":"Delvaux","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000090312","article-title":"Peripheral opioids for functional GI disease: a reappraisal","volume":"24","author":"Lembo","year":"2006","journal-title":"Dig Dis"},{"key":"10.1016\/j.gtc.2011.01.001_bib56","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1023\/A:1020545017390","article-title":"Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms","volume":"47","author":"Palsson","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2011.01.001_bib57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1542-3565(03)70039-1","article-title":"The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study","volume":"1","author":"Kuiken","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.gtc.2011.01.001_bib58","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/gut.2005.077503","article-title":"A\u00a0controlled cross-over study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome","volume":"55","author":"Tack","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.01.001_bib59","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2982.2007.00934.x","article-title":"Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans","volume":"19","author":"Houghton","year":"2007","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2011.01.001_bib60","doi-asserted-by":"crossref","first-page":"G295","DOI":"10.1152\/ajpgi.90558.2008","article-title":"Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects","volume":"296","author":"Sweetser","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.gtc.2011.01.001_bib61","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2036.2008.03881.x","article-title":"Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome\u2013results of two randomized, placebo-controlled studies","volume":"29","author":"Drossman","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib62","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.bjp.0703040","article-title":"Role of tachykinin NK2 receptors in normal and altered rectal sensitivity in rats","volume":"129","author":"Toulouse","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.gtc.2011.01.001_bib63","doi-asserted-by":"crossref","first-page":"G558","DOI":"10.1152\/ajpgi.00360.2002","article-title":"Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans","volume":"284","author":"Delgado-Aros","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.gtc.2011.01.001_bib64","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2036.2004.01922.x","article-title":"Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome","volume":"20","author":"Delvaux","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2036.2008.03730.x","article-title":"Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome","volume":"28","author":"Mangel","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib66","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1365-2036.2008.03676.x","article-title":"Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia","volume":"27","author":"Talley","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib67","first-page":"G997","article-title":"Adrenergic modulation of human colonic motor and sensory function","volume":"273","author":"Bharucha","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.gtc.2011.01.001_bib68","doi-asserted-by":"crossref","first-page":"G1468","DOI":"10.1152\/ajpgi.2001.281.6.G1468","article-title":"Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans","volume":"281","author":"Viramontes","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.gtc.2011.01.001_bib69","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2982.2009.01263.x","article-title":"Pharmacogenetics of low dose clonidine in irritable bowel syndrome","volume":"21","author":"Camilleri","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.gtc.2011.01.001_bib70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/cgh.2003.50019","article-title":"A\u00a0randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome","volume":"1","author":"Camilleri","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2011.01.001_bib71","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/gut.2006.101675","article-title":"Functional GI disorders: from animal models to drug development","volume":"57","author":"Mayer","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.01.001_bib72","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0028-3908(00)00205-7","article-title":"Responses of rat spinal neurons to distension of inflamed colon: role of tachykinin NK2 receptors","volume":"40","author":"Laird","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.gtc.2011.01.001_bib73","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00006842-200109000-00014","article-title":"Psychological and physiological responses to postprandial mental stress in women with the irritable bowel syndrome","volume":"63","author":"Elsenbruch","year":"2001","journal-title":"Psychosom Med"},{"key":"10.1016\/j.gtc.2011.01.001_bib74","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1023\/A:1010671514618","article-title":"Autonomic nervous system function in women with irritable bowel syndrome","volume":"46","author":"Heitkemper","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gtc.2011.01.001_bib75","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1023\/A:1016424007454","article-title":"Evidence for autonomic dysregulation in the irritable bowel syndrome","volume":"47","author":"Gupta","year":"2002","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.gtc.2011.01.001_bib76","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1053\/j.gastro.2009.08.058","article-title":"Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome","volume":"137","author":"Videlock","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib77","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2003.09.028","article-title":"Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS","volume":"125","author":"Dunlop","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib78","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ajg.2008.94","article-title":"Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms","volume":"104","author":"Cremon","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.01.001_bib79","doi-asserted-by":"crossref","unstructured":"Barbara G, Cremon C, Vicini R, et al. Excitatory effects of colonic mast cell mediators of irritable bowel syndrome patients on enteric cholinergic motor neurones. 2005:49.","DOI":"10.1016\/S1590-8658(06)80084-8"},{"issue":"4","key":"10.1016\/j.gtc.2011.01.001_bib80","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1053\/j.gastro.2009.07.005","article-title":"Activation of human enteric neurons by supernatants of colonic biopsies from patients with irritable bowel syndrome","volume":"137","author":"Buhner","year":"2009","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gtc.2011.01.001_bib81","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2036.2009.04041.x","article-title":"Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof of concept study","volume":"30","author":"Corinaldesi","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib82","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2007.01.046","article-title":"Immune activation in patients with irritable bowel syndrome","volume":"132","author":"Liebregts","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib83","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ajg.2009.116","article-title":"T-cell activation in patients with irritable bowel syndrome","volume":"104","author":"Ohman","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.01.001_bib84","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ajg.2008.86","article-title":"Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome","volume":"104","author":"Langhorst","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.01.001_bib85","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/gut.2007.140210","article-title":"Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity","volume":"57","author":"Gecse","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.01.001_bib86","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/gut.2008.150722","article-title":"Protease-activated receptor-2 activation: a major actor in intestinal inflammation","volume":"57","author":"Hyun","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.01.001_bib87","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1572-0241.2005.40312.x","article-title":"Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR","volume":"100","author":"Malinen","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.01.001_bib88","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.femsim.2004.08.009","article-title":"Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome\u2013a longitudinal study in IBS and control subjects","volume":"43","author":"Matto","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.gtc.2011.01.001_bib89","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-230X-9-95","article-title":"Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers","volume":"9","author":"Krogius-Kurikka","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gtc.2011.01.001_bib90","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/MPG.0b013e31815ce599","article-title":"Molecular studies of fecal anaerobic commensal bacteria in acute diarrhea in children","volume":"46","author":"Balamurugan","year":"2008","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.gtc.2011.01.001_bib91","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.chom.2007.08.002","article-title":"Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae","volume":"2","author":"Lupp","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.gtc.2011.01.001_bib92","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000228558","article-title":"The microbiota in inflammatory bowel disease in different age groups","volume":"27","author":"Cucchiara","year":"2009","journal-title":"Dig Dis"},{"issue":"10","key":"10.1016\/j.gtc.2011.01.001_bib93","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1365-2982.2008.01166.x","article-title":"Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients","volume":"20","author":"Schoepfer","year":"2008","journal-title":"Neurogastroenterol Motil"},{"issue":"8","key":"10.1016\/j.gtc.2011.01.001_bib94","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-2036.2009.03975.x","article-title":"Use of serum biomarkers in a diagnostic test for irritable bowel syndrome","volume":"29","author":"Lembo","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gtc.2011.01.001_bib95","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cgh.2009.12.018","article-title":"Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes?","volume":"8","author":"Spiller","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2011.01.001_bib96","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1398-9995.1996.tb04471.x","article-title":"Prevalence of adverse reactions to food in patients with gastrointestinal disease","volume":"51","author":"Bischoff","year":"1996","journal-title":"Allergy"},{"key":"10.1016\/j.gtc.2011.01.001_bib97","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/00042737-200012090-00003","article-title":"Symptoms discriminate irritable bowel syndrome from organic gastrointestinal diseases and food allergy","volume":"12","author":"Neri","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gtc.2011.01.001_bib98","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1572-0241.2005.41348.x","article-title":"Food-specific serum IgG4 and IgE titers to common food antigens in irritable bowel syndrome","volume":"100","author":"Zar","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gtc.2011.01.001_bib99","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1365-2222.2007.02727.x","article-title":"Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia","volume":"37","author":"Zuo","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.gtc.2011.01.001_bib100","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/gut.2003.037697","article-title":"Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial","volume":"53","author":"Atkinson","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2011.01.001_bib101","first-page":"377","article-title":"Intestinal permeability in irritable bowel syndrome. Effect of diet and sodium cromoglycate administration","volume":"64","author":"Paganelli","year":"1990","journal-title":"Ann Allergy"},{"key":"10.1016\/j.gtc.2011.01.001_bib102","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1053\/gast.2002.34780","article-title":"Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome","volume":"123","author":"Camilleri","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2011.01.001_bib103","first-page":"552","volume":"45","author":"Li","year":"2006","journal-title":"Zhonghua Nei Ke Za Zhi"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855311000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855311000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T08:38:02Z","timestamp":1712219882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855311000021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0889855311000021"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2011.01.001","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}